1. Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study. (May 2016) Authors: Khodneva, Yulia; Shalev, Anath; Frank, Stuart J.; Carson, April P.; Safford, Monika M. Journal: Diabetes research and clinical practice Issue: Volume 115(2016) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Issue 2 (April 2018) Authors: Thielen, Lance; Shalev, Anath Journal: Current opinion in endocrinology, diabetes and obesity Issue: Volume 25:Issue 2(2018:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lack of TXNIP protects β-cells against glucotoxicity. (19th September 2008) Authors: Shalev, Anath Journal: Biochemical Society transactions Issue: Volume 36:Number 5(2008) Page Start: 963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LDB1-mediated transcriptional complexes are sensitive to islet stress. Issue 1 (31st December 2022) Authors: Liu, Yanping; Kepple, Jessica D.; Shalev, Anath; Hunter, Chad S. Journal: Islets Issue: Volume 14:Issue 1(2022) Page Start: 58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗